LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,737 | 1,879 | 2,737 | 3,405 | 3,363 |
| TOTAL | $10,784 | $1,946 | $2,813 | $3,430 | $3,403 |
| Non-Current Assets | |||||
| PPE Net | 37 | 37 | N/A | N/A | N/A |
| TOTAL | $37 | $37 | $N/A | $N/A | $N/A |
| Total Assets | $10,821 | $1,983 | $2,813 | $3,430 | $3,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 473 | 176 | 69 | 92 | 68 |
| Accrued Expenses | 104 | 132 | 202 | 124 | 146 |
| Other current liabilities | N/A | N/A | N/A | N/A | 12,717 |
| TOTAL | $577 | $308 | $271 | $216 | $12,931 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 5,800 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $5,800 |
| Total Liabilities | $577 | $308 | $271 | $216 | $18,731 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,404 | 610 | 610 | 378 | 271 |
| Common Shares | 21 | 3 | 2 | 1 | 5 |
| Retained earnings | -458,904 | -454,730 | -451,569 | -447,366 | -444,261 |
| Other shareholders' equity | 10,331 | 11,312 | 10,888 | 10,907 | 0 |
| TOTAL | $10,244 | $1,675 | $2,542 | $3,214 | $-15,328 |
| Total Liabilities And Equity | $10,821 | $1,983 | $2,813 | $3,430 | $3,403 |